DIANORM TOTAL 60 (Gliclazide (60mg) + Pioglitazone (15mg) + Metformin (500mg))

Dianorm Total 60 Tablet SR is a medication utilized in the management of type 2 diabetes mellitus, which assists individuals in regulating their blood sugar levels. This treatment is indicated for adult patients diagnosed with diabetes. It is recommended to administer this medication alongside food, ideally at the same time every day, allowing for consistent absorption and effect. The prescribing physician will determine the appropriate dosage tailored to each patient’s needs, which may be adjusted periodically based on the results of blood glucose monitoring. It is crucial to continue using this medication even if you feel well or if your blood glucose levels appear stable. Abruptly discontinuing the medication without medical advice can lead to increased blood sugar levels, potentially resulting in serious health complications such as kidney damage, vision loss, nerve issues, and the possibility of limb loss. This medication should be viewed as one component of a comprehensive diabetes management plan that includes adhering to a balanced diet, engaging in regular physical activity, and achieving weight loss as instructed by your healthcare provider. Lifestyle modifications play a significant role in the effective management of diabetes. Among the commonly noted adverse effects of this medication is the risk of hypoglycemia, or low blood sugar levels. It is important to be aware of the symptoms associated with hypoglycemia, including sweating, dizziness, and headaches, and to understand how to respond to these symptoms appropriately. To mitigate the risk of low blood sugar, maintaining a routine meal schedule and having quick sources of glucose like sugary snacks or fruit juices readily available is recommended. It is also advisable to refrain from alcohol consumption, as it may exacerbate the risk of hypoglycemia. Additional potential side effects may include nausea, alterations in taste, diarrhea, abdominal discomfort, headaches, swelling, blurred vision, an increased likelihood of bone fractures, and upper respiratory infections. Weight gain may also be observed in certain individuals on this medication. This treatment should not be administered to those with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic conditions. Prior to starting this medication, it is essential to discuss any history of cardiac disease with your healthcare provider, as it may not be advisable. Women who are pregnant or breastfeeding should seek medical consultation before initiating this treatment. Regular monitoring of blood glucose levels is necessary, alongside potential blood tests to evaluate blood cell counts and liver health.